Demonstrates improved biomarker selection in genomic data, suggesting a new approach for discovery.
In high-dimensional genomic data, the curse of dimensionality (d ≫ n) and limited sampling make feature selection inherently unstable—a critical barrier to biomarker discovery. We introduce StackFeat, an iterative algorithm that accumulates two statistics across repeated cross-validation: signed coefficients (measuring effect strength and direction) and selection frequencies (estimating selection probability). Only features ranking highly by both criteria are retained. On a COVID-19 miRNA dataset (GSE240888), StackFeat identified a stable 5-miRNA signature from 332 features (98.5% reduction), achieving AUC 0.922, significantly outperforming the benchmark 9-gene set (AUC 0.907, p = 0.0016). The signature includes hsa-miR-150-5p, a marker implicated in both COVID-19 survival and Dengue infection. This dual-criterion approach provides convergence guarantees absent in single-criterion methods, enabling discovery of known biomarkers, novel candidates, and previously unknown relationships.
No takes yet. Share an insight, caveat, or question.
Yermekov et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: